Neurological disorders such as Alzheimer's disease, stroke, and brain cancers are difficult to
treat with current drugs as their delivery efficacy to the brain is severely hampered by the …

Codelivery of chemotherapeutics via nanomaterials has attracted much attention over the
last decades due to improved drug delivery to tumor tissues, decreased systemic effects …

Abstract Poly-ε-caprolactone (PCL) has been the subject of extensive research in the past
few years. It is widely explored in drug delivery, where the development of nanomedicines …

Cancer is a devastating disease that claims over 8 million lives each year. Understanding
the molecular etiology of the disease is critical to identify and develop new therapeutic …

The use of nanoparticles as biomaterials with applications in the biomedical field is growing
every day. These nanomaterials can be used as contrast imaging agents, combination …

In recent decades, many novel methods by using nanoparticles (NPs) have been
investigated for diagnosis, drug delivery and treatment of cancer. Accordingly, the potential …

One of the critical issues in the cancer tussle is the innovation of drug delivery platforms for
the extremely selective, controlled, and sustained release of anti-cancer drugs. We herein …

Aim of the studies to synthesized chitosan nanoparticles by an ionic interaction procedure.
The nanoparticles were characterized by physicochemical methods like, DLS, TEM, Surface …

Limitations associated with the use of linear biodegradable polyesters in the preparation of
anticancer nano-based drug delivery systems (nanoDDS) have turned scientific attention to …

Abstract Poly (ε-caprolactone)(PCL) nanoparticles (NPs) offer many possibilities for drug
transport because of their good physicochemical properties and biocompatibility …